benefits of semaglutide and tirzepatide Why GLP-1 drugs like deliver different weight loss results for different people, and why lifestyle, metabolism, and medical supervision matter Semaglutide vs. Tirzepatide: Which Weight

The following table provides general timelines based on the type of procedure you have undergone

doi:10.1002/edm2.112

Back to Journals Clinical Ophthalmology Volume 20 Glucagon-Like Peptide-1 Analogs Associated with a Reduced Risk of Legal Blindness in Type 2 Diabetics with Cardiovascular Risks Authors Jarrett E, Muayad J , Ryu BU, Lee AG, Gupta PK Received 1 December 2025 Accepted for publication 28 January 2026 Published 3 February 2026 Volume 2026:20 581826 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Yousef Fouad Ethan Jarrett, 1 Jawad Muayad, 2 Byoung U Ryu, 3 Andrew G Lee, 1 8 Praveena K Gupta 3 1 John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX, USA

Unlike approved agents such as semaglutide (Wegovy) or tirzepatide (Zepbound), retatrutide has not yet received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for use in the United Kingdom

Clinical trials show phentermine produces 5-10% body weight loss over 3-6 months